Cargando…

Integrin α6β4 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin

Integrin α6β4 is highly expressed in triple negative breast cancer (TNBC) and drives its most aggressive traits; however, its impact on chemotherapeutic efficacy remains untested. We found that integrin α6β4 signaling promoted sensitivity to cisplatin and carboplatin but not to other chemotherapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Min, Marrs, Brock, Qi, Lei, Knifley, Teresa, Weiss, Heidi L., D’Orazio, John A., O’Connor, Kathleen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686853/ https://www.ncbi.nlm.nih.gov/pubmed/36439467 http://dx.doi.org/10.3389/fonc.2022.1043538

Ejemplares similares

LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells
por: Harrison, Susan MW, et al.
Publicado: (2013)

Rhoa Function in Lamellae Formation and Migration Is Regulated by the α6β4 Integrin and Camp Metabolism
por: O'Connor, Kathleen L., et al.
Publicado: (2000)

Targeting integrin α5β1 in urological tumors: opportunities and challenges
por: Zhou, Xuming, et al.
Publicado: (2023)

Use of Synthetic Isoprenoids to Target Protein Prenylation and Rho GTPases in Breast Cancer Invasion
por: Chen, Min, et al.
Publicado: (2014)

In vivo evaluation of integrin αvβ6-targeting peptide in NSCLC and brain metastasis
por: Fan, Di, et al.
Publicado: (2023)

Release of cAMP Gating by the α6β4 Integrin Stimulates Lamellae Formation and the Chemotactic Migration of Invasive Carcinoma Cells
por: O'Connor, Kathleen L., et al.
Publicado: (1998)

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells
por: Phanthaphol, Nattaporn, et al.
Publicado: (2021)

p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer
por: Deng, Xinyue, et al.
Publicado: (2020)

Integrin α6β4 Upregulates Amphiregulin and Epiregulin through Base Excision Repair-Mediated DNA Demethylation and Promotes Genome-wide DNA Hypomethylation
por: Carpenter, Brittany L., et al.
Publicado: (2017)

S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide
por: Stewart, Rachel L., et al.
Publicado: (2016)

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin
por: Liu, Qing, et al.
Publicado: (2020)

SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a (177)Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model
por: Sachindra, Sachindra, et al.
Publicado: (2021)

LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway
por: Zeng, Xiaofei, et al.
Publicado: (2020)

Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin
por: Wang, Jia, et al.
Publicado: (2020)

Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy
por: Moretton, Amandine, et al.
Publicado: (2022)

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021)

Pentoxifylline Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment: Involvement of Mitochondrial and NF-Kappa B Pathways
por: Bravo-Cuellar, Alejandro, et al.
Publicado: (2020)

Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
por: Zhao, Xiaopeng, et al.
Publicado: (2022)

Upregulated integrin α11 in the stroma of cutaneous squamous cell carcinoma promotes skin carcinogenesis
por: Martínez-Nieto, Guillermo A., et al.
Publicado: (2022)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
por: Roblek, Marko, et al.
Publicado: (2022)

Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells
por: Gajan, Ambikai, et al.
Publicado: (2021)

Evaluation of a CD13 and Integrin α(v)β(3) Dual-Receptor Targeted Tracer (68)Ga-NGR-RGD for Ovarian Tumor Imaging: Comparison With (18)F-FDG
por: Long, Yu, et al.
Publicado: (2022)

Integrins and ERp57 Coordinate to Regulate Cell Surface Calreticulin in Immunogenic Cell Death
por: Liu, Chi-Chao, et al.
Publicado: (2019)

Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway
por: Shang, Lei, et al.
Publicado: (2019)

Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer
por: Contreras-Romero, Carlos, et al.
Publicado: (2022)

Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells
por: Gong, Baocheng, et al.
Publicado: (2021)

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients
por: de Kruijff, I. E., et al.
Publicado: (2021)

Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells
por: Gong, Baocheng, et al.
Publicado: (2022)

Integrin β6 deficiency protects mice from experimental colitis and colitis-associated carcinoma by altering macrophage polarization
por: Sun, Qi, et al.
Publicado: (2023)

Tumor Targeting via Integrin Ligands
por: Marelli, Udaya Kiran, et al.
Publicado: (2013)

Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway
por: Wang, Xi, et al.
Publicado: (2020)

Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2017)

Calpains promote α2β1 integrin turnover in nonrecycling integrin pathway
por: Rintanen, Nina, et al.
Publicado: (2012)

Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
por: Bieg, Dominik, et al.
Publicado: (2018)

A specialized integrin-binding motif enables proTGF-β2 activation by integrin αVβ6 but not αVβ8
por: Le, Viet Q., et al.
Publicado: (2023)

The integrin ligand SVEP1 regulates GPCR‐mediated vasoconstriction via integrins α9β1 and α4β1
por: Morris, Gavin E., et al.
Publicado: (2022)

Cadherins, Selectins, and Integrins in CAM-DR in Leukemia
por: Kim, Hye Na, et al.
Publicado: (2020)

Integrin-Mediated Tumorigenesis and Its Therapeutic Applications
por: Li, Qingling, et al.
Publicado: (2022)

αV-class integrins exert dual roles on α5β1 integrins to strengthen adhesion to fibronectin
por: Bharadwaj, Mitasha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ph5rm26eesdl4ucn58dtce3ank